Breaking News Instant updates and real-time market news.

MLHR

Herman Miller

$35.07

-0.85 (-2.37%)

, MU

Micron

$40.08

-0.3 (-0.74%)

18:46
03/20/19
03/20
18:46
03/20/19
18:46

Fly Intel: After Hours Movers

UP AFTER EARNINGS: Herman Miller (MLHR) up 6.3%... Micron (MU) up 4.7%... Williams-Sonoma (WSM) up 3.4%. ALSO HIGHER: Sientra (SIEN) up 2.5% after responding to FDA letter on implants, expecting no impact on operations... Eventbrite (EB) up 2.1% after disclosing Point72 stake. DOWN AFTER EARNINGS: Guess (GES) down 13.9%... Uniti Group (UNIT) down 4.2%... Wex (WEX) down 2.0%. ALSO LOWER: Cellular Biomedicine (CBMG) down 7.1% after equity offering... Frontdoor (FTDR) down 3.3% after equity offering. Movers as of 18:30ET.

MLHR

Herman Miller

$35.07

-0.85 (-2.37%)

MU

Micron

$40.08

-0.3 (-0.74%)

WSM

Williams-Sonoma

$56.88

0.09 (0.16%)

SIEN

Sientra

$9.76

0.945 (10.73%)

EB

Eventbrite

$20.09

-0.72 (-3.46%)

GES

Guess

$22.10

-0.41 (-1.82%)

UNIT

Uniti Group

$10.01

0.15 (1.52%)

WEX

Wex

$184.85

-1.465 (-0.79%)

CBMG

Cellular Biomedicine

$18.26

0.38 (2.13%)

FTDR

Frontdoor

$32.10

-2.29 (-6.66%)

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 02

    Apr

  • 03

    Apr

  • 21

    Mar

  • 21

    Mar

MLHR Herman Miller
$35.07

-0.85 (-2.37%)

MU Micron
$40.08

-0.3 (-0.74%)

03/18/19
MSCO
03/18/19
NO CHANGE
MSCO
Equal Weight
Morgan Stanley surprised Micron didn't preannounce
Morgan Stanley analyst Joseph Moore said he is "frankly surprised" that Micron did not preannounce its Q2 results given the weakness seen in its markets since the company gave guidance in mid-December and he expects a "tough quarter" when the company reports on Wednesday after the close. The market expectation when the company gave guidance was calendar first quarter server DRAM pricing would be $230, but pricing started the quarter at $200 and has since moved down to currently about $150, Moore noted. The analyst, who thinks the biggest question is how long conditions will continue to deteriorate, doesn't expect to get definitive answers on that this quarter but said that he continues to see "discouraging lead indicators." Moore keeps an Equal Weight rating on Micron shares.
03/18/19
MKMP
03/18/19
NO CHANGE
Target $44
MKMP
Buy
Micron earnings estimates reduced at MKM Partners
MKM Partners analyst Ruben Roy kept his Buy rating and $44 price target on Micron but lowered his FY19 EPS view to $7.01 from $8.14 and his FY20 outlook to $6.05 from $7.91 ahead of its next earnings report next week. The analyst cites demand trends in the server and handset markets remaining "challenged", along with the continued pricing deterioration over the past several months. In spite of his lower average-selling-price assumptions however, Roy recommends that investors with longer term horizon continue to hold Micron, anticipating "solid operating margins and profitability" for the company this year.
03/18/19
STPT
03/18/19
UPGRADE
STPT
Buy
Micron upgraded to Buy from Hold at Standpoint Research
03/19/19
SBSH
03/19/19
NO CHANGE
Target $35
SBSH
Neutral
Citi predicts 'DRAM crash,' sees no second half recovery for Micron
The Micron Technology bulls think we are at or approaching the bottom and that a recovery will happen in the second half of 2019, Citi analyst Christopher Danely tells investors in a pre-earnings research note, citing his talks with investors. The analyst, however, disagrees with this thesis based on his channel checks and supply/demand model. He believes memory selling prices could bottom in the second half of 2019, not the first half. All three DRAM producers are stockpiling inventory in order to prevent flooding the market with excess of supply, Danely tells investors in a research note. He believes current production rates remain well ahead of demand and that the excess inventory on the balance sheets of the memory companies will need to be written down or written off. The analyst estimates that normal DRAM channel inventory is one month and it's at three months now "only due to producers holding inventory." In a research note titled "Earnings Preview: Don't Go Away Mad...Just Go Away. It's Only Getting Worse, No 2H recovery for Micron Due to DRAM Crash," Danely reiterates a Neutral rating on Micron Technology with a $35 price target. The chipmaker closed yesterday up 7c to $39.61. He expects in-line fiscal Q2 results on when the company reports on March 20 but sees downside to 2019 and 2020 estimates "due to the DRAM Crash."
WSM Williams-Sonoma
$56.88

0.09 (0.16%)

01/23/19
01/23/19
DOWNGRADE
Target $49

Underweight
Morgan Stanley downgrades Williams-Sonoma to Underweight on intensified pressure
As previously reported, Morgan Stanley analyst Simeon Gutman downgraded Williams-Sonoma to Underweight from Equal Weight as he believes top and bottom-line pressures will intensify in 2019. He projects same-store sales growth may slow more than the market is expecting in 2019 due to moderating Pottery Barn sales, a slowdown in consumer spending and competition "reaching new heights in home furnishings." Additionally, Williams-Sonoma is more exposed to tariffs than most retailers he covers, Gutman noted. He cut his price target on Williams-Sonoma shares to $49 from $55.
03/20/19
EVER
03/20/19
INITIATION
Target $60
EVER
In Line
Williams-Sonoma initiated with an In Line at Evercore ISI
Evercore ISI analyst Oliver Wintermantel started Williams-Sonoma with an In Line rating and $60 base case price target, stating that the company has made very good progress in transforming into a true multichannel retailer. However, the current multiple assumes further profitability declines, as does his model.
01/23/19
01/23/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Underperform from Sector Perform at RBC Capital with analyst Joseph Spak saying the company's more "tactful messaging" conveys downward pressure to growth expectations and also sees the "realities" of Tesla becoming a volume player highlighting its "challenges to scale and deliver high volume at high ASPs/margins." 2. Lowe's (LOW) downgraded to Hold from Buy at Loop Capital with analyst Laura Champine saying she thinks she was previously too optimistic on Lowe's likely margin progression. 3. Williams-Sonoma (WSM) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman saying he believes top and bottom-line pressures will intensify in 2019. 4. Merck (MRK) downgraded to Market Perform from Outperform at BMO Capital with analyst Alex Arfaei citing the company's over-dependence on Keytruda, the Street's high expectations, and his views on upcoming competitor trials combining for a more balanced risk-reward on Merck. 5. Pfizer (PFE) and Mylan (MYL) were downgraded to Neutral from Buy at UBS. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/23/19
MSCO
01/23/19
DOWNGRADE
MSCO
Underweight
Williams-Sonoma downgraded to Underweight from Equal Weight at Morgan Stanley
SIEN Sientra
$9.76

0.945 (10.73%)

03/13/19
SPHN
03/13/19
NO CHANGE
Target $26
SPHN
Overweight
Sientra growth outlook remains effectively on-track, says Stephens
Stephens analyst Chris Cooley reiterated his Overweight rating and $26 price target on Sientra shares following the company's Q4 report, contending that its growth outlook "remains effectively on-track." He still thinks investors should accumulate the shares at "historically trough multiples in med tech" to benefit from the expected acceleration in growth during the second half of 2019, Cooley tells investors in a post-earnings research note.
03/13/19
STFL
03/13/19
NO CHANGE
Target $16
STFL
Buy
Sientra price target lowered to $16 after quarterly results at Stifel
Stifel analyst Jonathan Block lowered his price target lowered to $16 from $19 saying that while Q4 results were largely known, the company provided a tempered first half of 2019 outlook. The analyst notes that Sientra had already preannounced Q4 results in January, but points out that there were a couple of incremental data points on the conference call that may exert some near-term pressure on the stock, including recent headlines surrounding ALCL and textured implants that have pressured the number of Plastic Surgeon breast augmentation consultations in Q1, which may continue into Q2. Nonetheless, Block reiterates a Buy rating on the shares.
03/14/19
WELS
03/14/19
INITIATION
Target $9
WELS
Market Perform
Sientra initiated with a Market Perform at Wells Fargo
Wells Fargo analyst David Maris started coverage of Sientra with a Market Perform rating and a $9 price target. The analyst says he is on the sidelines given the FDA is holding meetings on March 25-26 to discuss breast implant safety and the result could be increased monitoring and warnings, which could have a negative impact on costs and volumes.
03/19/19
WELS
03/19/19
NO CHANGE
Target $9
WELS
Market Perform
Sientra implied costs to gain FDA compliance negligible, says Wells Fargo
Wells Fargo analyst David Maris kept his Market Perform rating and $9 price target on Sientra after the company disclosed an FDA warning letter for failure to comply with the post-approval study requirements for its silicone gel breast implants. The analyst notes that he spoke with the management, and they believe that the FDA is targeting a patient follow-up rate of 65% at the end of 10 years after the study vs. the company's current 61% at year 3. Maris adds that given about 5K patients in the study with $100-$200 implied cost per patient, the required incremental cost to address FDA concerns is "negligible" relative to the company's current operating expenses.
EB Eventbrite
$20.09

-0.72 (-3.46%)

03/08/19
RHCO
03/08/19
NO CHANGE
Target $28
RHCO
Hold
Eventbrite price target lowered to $28 from $32 at SunTrust
SunTrust analyst Youssef Squali lowered his price target on Eventbrite to $28 and kept his Hold rating after its "mixed" Q4 results and disappointing Q1 outlook that was "well below consensus" on revenue and EBITDA. The analyst attributes the downside to the "longer and harder to implement" integration and migration of Ticketfly creators onto the Eventbrite platform. Squali is also concerned with the lack of short-term catalysts and the stock price impact of the upcoming IPO lock-up expiration on March 18th.
01/08/19
NOMU
01/08/19
NO CHANGE
Target $108
NOMU
Buy
Eventbrite could meaningfully boost Square payment volumes, says Nomura Instinet
Square (SQ) this year will begin to process payment volumes for Eventbrite (EB), a fast growing event ticketing website, in the U.S. and other major geographies. Nomura Instinet analyst Dan Dolev tells investors in a research note titled "Eventbrite Could Meaningfully Boost GPV." The analyst estimates Eventbrite could contribute $2B-$4B in 2019 to Square's gross payment volume and $5M-$11M to adjusted net revenue. He does not believe Eventbrite's contribution is reflected in consensus estimates. Dolev raised his price target for Square shares to $108 from $107 and keeps a Buy rating on the name.
12/20/18
12/20/18
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Macerich (MAC) downgraded to Sector Weight from Overweight at KeyBanc. 2. Eventbrite (EB) downgraded to Hold from Buy at Stifel with analyst Scott Devitt citing valuation. 3. HSBC (HSBC) downgraded to Sell from Hold at Edward Jones. 4. Noble Corp (NE) and Ensco (ESV) were downgraded to Hold from Buy at Societe Generale. 5. Greif (GEF) downgraded to Underperform from Outperform at BMO Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/08/19
RBCM
03/08/19
NO CHANGE
Target $30
RBCM
Outperform
Eventbrite price target lowered to $30 from $37 at RBC Capital
RBC Capital analyst Mark Mahaney lowered his price target on Eventbrite after its mixed Q4 results and a miss in its guidance, saying the quarter highlights the company's "execution challenges" and makes him "less constructive" on the stock. The analyst is keeping his positive stance and Outperform rating on Eventbrite however, citing the quarter's "consistent revenue growth and EBITDA margin expansion of 11bps along with the 18% paid ticket growth and product launches in international markets". Mahaney also continues to view Eventbrite as well positioned to address "a very large and fragmented total market opportunity with powerful secular tailwinds."
GES Guess
$22.10

-0.41 (-1.82%)

02/07/19
JEFF
02/07/19
UPGRADE
Target $24
JEFF
Buy
Guess upgraded to Buy from Hold at Jefferies
Jefferies analyst Janine Stichter upgraded Guess to Buy with a $24 price target.
02/07/19
JEFF
02/07/19
UPGRADE
Target $24
JEFF
Buy
Jefferies upgrades Guess to Buy following recent share pullback
Jefferies analyst Janine Stichter upgraded Guess to Buy from Hold with an unchanged price target of $24. The recent pullback in the stock puts the company's multiple below its historical average and peers, Stichter tells investors in a research note. This presents an opportunity to own one of the few remaining retailers with both top-line growth and potential for margin expansion, the analyst writes. Further, she views the management change as an opportunity, not a sign of current weakness. Stichter also sees a "substantial runway for growth ahead" in Europe and Asia for Stichter, while pointing out that data suggest inflecting North America momentum.
02/07/19
02/07/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Saia (SAIA) upgraded to Buy from Hold at Deutsche Bank with analyst Amit Mehrotra saying after meeting with management, he is incrementally more confident in Saia's ability to generate double-digit revenue growth this year. 2. Guess (GES) upgraded to Buy from Hold at Jefferies with analyst Janine Stichter saying the recent pullback in the stock puts the company's multiple below its historical average and peers. 3. Spirit Airlines (SAVE) upgraded to Buy from Neutral at Goldman Sachs with analyst Catherine O'Brien saying she expects passenger revenue trends for the company in the first half of the year to be stronger than previously anticipated. 4. MacroGenics (MGNX) upgraded to Buy from Sell at Citi with analyst Yigal Nochomovitz saying additional Phase 1 readouts in 2019 should provide further stock momentum for MacroGenics. 5. Cognizant (CTSH) upgraded to Outperform from Market Perform at BMO Capital with analyst Keith Bachman citing the company's FY19 revenue growth outlook and a positive management transition. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
UNIT Uniti Group
$10.01

0.15 (1.52%)

03/05/19
WELS
03/05/19
DOWNGRADE
WELS
Underperform
Uniti Group downgraded to Underperform from Market Perform at Wells Fargo
03/05/19
03/05/19
DOWNGRADE
Target $8

Underperform
Uniti Group downgraded to Underperform on too much uncertainty at Wells Fargo
As previously reported, Wells Fargo analyst Jennifer Fritzsche downgraded Uniti Group (UNIT) to Underperform from Market Perform and lowered her price target on the shares to $8 from $17. The analyst notes that the company released an 8K which indicated a significant cut in the dividend. Fritzsche believes the February 15 ruling against Windstream (WIN) in its case versus Aurelius Capital Management, and the ripple effect on Uniti including a delay of the company's Q4 earnings and potential default in its credit agreement, has introduced a great degree of uncertainty into the story. While the analyst continues to believe Uniti's fiber assets are attractive, the company's path toward diversifying away from its Windstream exposure has become more difficult to model.
03/05/19
03/05/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Uniti Group (UNIT) downgraded to Underperform from Market Perform at Wells Fargo with analyst Jennifer Fritzsche saying the company released an 8K which indicated a significant cut in the dividend. 2. Adamas Pharmaceuticals (ADMS) downgraded to Underperform from Neutral at Mizuho, to Market Perform from Outperform at Cowen, and to Hold from Buy at Needham. 3. SQM (SQM) downgraded to Neutral from Buy at Citi with analyst Andrew McCarthy saying he continues to like the long-term lithium demand story but does not expect share price outperformance over the next 12 months. 4. Orange SA (ORAN) downgraded to Equal Weight from Overweight at Barclays with analyst Mathieu Robilliard saying an "irrational level of promotions" in 2018 continue to weigh on French telecoms. 5. Inter Parfums (IPAR) downgraded to Neutral from Buy at DA Davidson with analyst Linda Bolton Weiser citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/19/19
SBSH
03/19/19
NO CHANGE
Target $8
SBSH
Sell
Uniti Group price target lowered to $8 from $11 at Citi
Citi analyst Michael Rollins lowered his price target for Uniti Group to $8 from $11 saying he remains concerned about the company's cash position and the continued demands on its balance sheet during 2019. He keeps a Sell rating on the shares.
WEX Wex
$184.85

-1.465 (-0.79%)

01/18/19
01/18/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tencent Music (TME) initiated with a Buy at HSBC. 2. Wex (WEX) and FleetCor (FLT) were initiated with a Buy at BTIG. 3. Joint Corp (JYNT) initiated with a Buy at DA Davidson. 4. York Water (YORW) initiated with a Buy at Janney Montgomery Scott. 5. Primerica (PRI) initiated with an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/28/19
JEFF
01/28/19
INITIATION
Target $210
JEFF
Hold
Wex initiated with a Hold at Jefferies
Jefferies analyst Michael Del Grosso initiated Wex with a Hold and $170price target.
01/28/19
JEFF
01/28/19
INITIATION
JEFF
Hold
Wex initiated with a Hold at Jefferies
Jefferies analyst Michael Del Grosso initiated coverage of Wex with a Hold rating and $170 price target. The analyst said that despite bright long-term growth prospects, the risk/reward is balanced at the stock's current valuation.
01/17/19
BTIG
01/17/19
INITIATION
Target $198
BTIG
Buy
Wex initiated with a Buy at BTIG
BTIG analyst Mark Palmer started Wex Inc. (WEX) with a Buy rating and $198 price target. The company is well positioned to not only meet its medium-term revenue and earnings targets, but also to achieve management's goal of doubling in size within the next five years, Palmer tells investors in a research note. Wex offers sustainable growth in business-to-business payments at an inexpensive, adds the analyst. He sees both FleetCor Technologies (FLT) and Wex as well positioned to benefit from the "ongoing cash-to-card displacement trend."
CBMG Cellular Biomedicine
$18.26

0.38 (2.13%)

02/06/19
BARD
02/06/19
INITIATION
Target $26
BARD
Cellular Biomedicine initiated with an Outperform at Baird
Baird analyst Madhu Kumar initiated Cellular Biomedicine (CBMG) with an Outperform rating and a price target of $26. The analyst says the company's manufacturing capacity in cell therapy provide it with an edge in the "underappreciated China market", while its partnership with Novartis' (NVS) Kymriah in China validates its cell therapy manufacturing prowess. Given the multiple cell therapies expected in the next 12 months, Kumar says Cellular Biomedicine "could have a panoply of shots on goal over the coming year."
FTDR Frontdoor
$32.10

-2.29 (-6.66%)

11/06/18
OPCO
11/06/18
NO CHANGE
Target $40
OPCO
Outperform
Frontdoor price target lowered to $40 from $48 at Oppenheimer
Oppenheimer analyst Ian Zaffino lowered his price target for Frontdoor to $40 from $48 saying that the company missed adjusted EBITDA, hurt by inflation, repair costs and more frequent service calls. Frontdoor lowered FY18 EBITDA guidance, owing to the miss and the unusually unfavorable weather in October, he adds. The analyst reiterates an Outperform rating on the shares.
11/30/18
BUCK
11/30/18
INITIATION
Target $29
BUCK
Buy
Frontdoor initiated with a Buy at Buckingham
Buckingham analyst James Clement initiated Frontdoor (FTDR) with a Buy rating and $29 price target. He believes the stock's "very poor" trading since its spinoff from ServiceMaster (SERV) on October 1 provides a buying opportunity, stating that Frontdoor is in the process of raising prices and he thinks it has plenty of room to do so. Clement believes the most attractive long-term aspect of the story is the potential for Frontdoor to be a disruptor in home improvement, maintenance and repairs, but acknowledges the company will have to invest significantly to make this a reality.
02/28/19
SPIN
02/28/19
UPGRADE
SPIN
Buy
Frontdoor upgraded to Buy from Hold at Spin-Off Research
10/03/18
SPIN
10/03/18
DOWNGRADE
SPIN
Hold
Frontdoor downgraded to Hold from Buy at Spin-Off Research

TODAY'S FREE FLY STORIES

12:45
04/19/19
04/19
12:45
04/19/19
12:45
General news
Breaking General news story  »

Week of 4/19 Baker-Hughes…

MMNFF

MedMen

$0.00

(0.00%)

11:13
04/19/19
04/19
11:13
04/19/19
11:13
Hot Stocks
MedMen announces resignations of COO and General Counsel »

MedMen Enterprises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TKC

Turkcell

$5.49

-0.175 (-3.09%)

11:08
04/19/19
04/19
11:08
04/19/19
11:08
Hot Stocks
Turkcell sees conclusion of $4.2B lawsuit against MTN this year »

The following statement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCCY

1st Constitution Bancorp

$18.07

-0.14 (-0.77%)

11:05
04/19/19
04/19
11:05
04/19/19
11:05
Earnings
1st Constitution Bancorp reports Q1 EPS 39c, two estimates 36c »

Robert Mangano, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QUMU

Qumu

$2.83

-0.035 (-1.22%)

11:03
04/19/19
04/19
11:03
04/19/19
11:03
Hot Stocks
Qumu announces death of director Thomas Madison »

Qumu Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 09

    May

FAT

Fat Brands

$5.15

0.065 (1.28%)

10:54
04/19/19
04/19
10:54
04/19/19
10:54
Hot Stocks
Fat Brands announces development of Fatburger concept in Albuquerque »

FAT Brands announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRTG

Heritage Insurance

$14.32

0.25 (1.78%)

10:52
04/19/19
04/19
10:52
04/19/19
10:52
Hot Stocks
Heritage Insurance announces preliminary Q1 catastrophe losses of $15.4M »

Heritage Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

COTY

Coty

$11.27

0.02 (0.18%)

10:48
04/19/19
04/19
10:48
04/19/19
10:48
Hot Stocks
Coty notes extension of tender offer by affiliate of JAB Holding Company »

Coty notes the extension…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTES

NetEase

$265.88

-2.34 (-0.87%)

10:45
04/19/19
04/19
10:45
04/19/19
10:45
Hot Stocks
NetEase announces music license agreement with Nippon Columbia »

NetEase Cloud Music…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:10
04/19/19
04/19
09:10
04/19/19
09:10
General news
Today's U.S. housing report revealed March declines »

Today's U.S. housing…

08:45
04/19/19
04/19
08:45
04/19/19
08:45
General news
U.S. housing starts fell 0.3% to 1.139 M in March »

U.S. housing starts fell…

08:15
04/19/19
04/19
08:15
04/19/19
08:15
General news
Housing Starts to be reported at 08:30 »

March Housing Starts will…

08:15
04/19/19
04/19
08:15
04/19/19
08:15
General news
Housing Starts Permits to be reported at 08:30 »

March Housing Starts…

08:05
04/19/19
04/19
08:05
04/19/19
08:05
General news
U.S. housing starts preview: »

U.S. housing starts…

NDEKY

Nitto Denko

$0.00

(0.00%)

06:53
04/19/19
04/19
06:53
04/19/19
06:53
Downgrade
Nitto Denko rating change at Goldman Sachs »

Nitto Denko downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CURO

Curo Group

$10.96

0.16 (1.48%)

04:55
04/19/19
04/19
04:55
04/19/19
04:55
Conference/Events
Curo Group management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 16

    May

  • 05

    Jun

  • 13

    Nov

04:55
04/19/19
04/19
04:55
04/19/19
04:55
General news
Breaking General news story  »

Week of 4/19 Baker-Hughes…

04:55
04/19/19
04/19
04:55
04/19/19
04:55
General news
Housing Starts Permits to be reported at 08:30 »

March Housing Starts…

AON

Aon plc

$175.38

-0.14 (-0.08%)

, MMC

Marsh & McLennan

$93.76

-0.62 (-0.66%)

04:55
04/19/19
04/19
04:55
04/19/19
04:55
Conference/Events
Willis Towers Watson »

Analyst Klauber holds a…

AON

Aon plc

$175.38

-0.14 (-0.08%)

MMC

Marsh & McLennan

$93.76

-0.62 (-0.66%)

WLTW

Willis Towers Watson

$177.37

0.45 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 25

    Apr

  • 26

    Apr

  • 01

    May

  • 07

    May

  • 16

    May

  • 20

    May

  • 11

    Jun

04:55
04/19/19
04/19
04:55
04/19/19
04:55
General news
Housing Starts to be reported at 08:30 »

March Housing Starts will…

ISRG

Intuitive Surgical

$528.04

3.29 (0.63%)

21:07
04/18/19
04/18
21:07
04/18/19
21:07
Recommendations
Intuitive Surgical analyst commentary at Piper Jaffray »

Intuitive Surgical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 25

    Apr

  • 03

    May

UBER

Uber

$0.00

(0.00%)

, TM

Toyota

$125.10

0.93 (0.75%)

20:35
04/18/19
04/18
20:35
04/18/19
20:35
Hot Stocks
Uber confirms investment from Toyota, DENSO and SoftBank Vision Fund »

Toyota Motor (TM), Denso…

UBER

Uber

$0.00

(0.00%)

TM

Toyota

$125.10

0.93 (0.75%)

DNZOY

Denso

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

FIX

Comfort Systems USA

$57.58

0.06 (0.10%)

20:08
04/18/19
04/18
20:08
04/18/19
20:08
Hot Stocks
Comfort Systems USA discloses ransomware attack virus »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 12

    Jun

  • 13

    Jun

NSANY

Nissan

$0.00

(0.00%)

, RNSDF

Renault

$0.00

(0.00%)

19:29
04/18/19
04/18
19:29
04/18/19
19:29
Periodicals
Nissan to cut global output by 15% in FY19/20, Nikkei reports »

Nissan Motor (NSANY) will…

NSANY

Nissan

$0.00

(0.00%)

RNSDF

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FE

FirstEnergy

$40.51

0.28 (0.70%)

19:13
04/18/19
04/18
19:13
04/18/19
19:13
Hot Stocks
FirstEnergy CEO 'pleased' FES submitted revised disclosure statement »

FirstEnergy Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.